Browsing by other project Ulm "BIU / Boehringer Ingelheim Ulm University BioCenter (BIU) / Forschungsverbund / BIU Phase II TP I3"
Now showing items 1-3 of 3
-
A tumor-specific neoepitope expressed in homologous/self or heterologous/viral antigens induced comparable effector CD8(+) T-cell responses by DNA vaccination
(2020)Wissenschaftlicher Artikel
-
Endogenously Expressed AntigensBind Mammalian RNA via Cationic Domains that Enhance Priming of Effector CD8 T Cells by DNA Vaccination
(2019)Wissenschaftlicher Artikel
-
IFN-gamma treatment protocol for MHC-I-lo/PD-L1(+)pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential
(2020)Wissenschaftlicher Artikel